Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université Laval

$42,000.00

Cellular and molecular mechanisms involved in the biosynthesis and hydrolysis of the endocannabinoid 2-arachidonoyl-glycerol and its congeners

EF 2023-24

Résumé
Arachidonic acid (AA) is fatty acid mainly found in animals. It plays critical roles in many processes, from fever to reproduction. AA is so important that animals unable to synthesize it, such as the cat, are obligatory carnivorous to obtain the AA from the meat they eat. Humans can however make it from vegetable oils containing linoleic acid. In our body, most of the AA is stored within our cell membranes. Multiple enzymes are responsible for storing AA within our cell membranes and for providing free AA on demand. AA is the precursor of numerous eicosanoids such as prostaglandins and leukotrienes, which participate to a myriad of physiological processes. AA is also the precursor of the main endocannabinoids, which mimic some of the physiological effects of cannabis, as well as displaying many other regulatory functions throughout our organism. Thus, it is not surprizing that AA levels are tightly controlled. Furthermore, many enzymes are involved in the degradation of AA-containing endocannabinoids, although the involved proteome is not completely defined. My NSERC research program focuses at understanding how arachidonic acid (AA) metabolism occurs in inflammatory cells and to define the regulatory mechanisms involved in AA turnover and release. This is important given the important role AA has at regulating the abovementioned functions, notably during the course of inflammation. We recently showed that the fate of AA is diverse in human neutrophils: 1) it is partly transformed into eicosanoids; 2) it is rapidly incorporated into phospholipids. Of note, 3) some of the reacylated AA is rereleased as 2-arachidonoylglycerol (2-AG), an endocannabinoid; While the first two events had previously been documented us and others, we are the first to document the release of 2-AG. The AA-induced 2-AG biosynthesis is prevented by Acyl-CoA synthetase and Acyl-CoA tranferase inhibition, indicating the remodeling of AA into phospholipids. To be adequately observed, we must eliminate the ability of leukocyte to hydrolyze 2-AG. For the next five years, we propose to define, at the cellular and molecular level, wether additional substrates participate to the biosynthetic pathway we unmaked. We will thus investigate numerous unsaturated fatty acids and oxylipins. Finally, and as underscored above, 2-AG is very labile and is hydrolyzed very rapidly (seconds to minutes). While defining which 2-AG lipases were expressed by neutrophils, we pinpointed a new 52 kDa protein not documented for hydrolyzing 2-AG. We will thus identify that protein by mass spectrometry. Once identified, we will confirm using recombinant proteins the selectivity and specificity of the enzyme. In conclusion, this project will provide important insights on the regulation of AA and AA-derived effectors. It will also provide useful data for the understanding of lipid mediator biosynthesis and their role in physiology and will confirm AA as a central regulator of 2-AG synthesis.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2021-03777
Name nom
Flamand, Nicolas
Department département
Médecine - Médecine
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2021
Award amount
42000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5408
Research subject group en
Biochemistry
Research subject group fr
Metabolism
Research subject en
Biochimie
Research subject fr
Métabolisme
Application title
Cellular and molecular mechanisms involved in the biosynthesis and hydrolysis of the endocannabinoid 2-arachidonoyl-glycerol and its congeners
Keyword
2-arachidonoyl-glycerol; arachidonic acid; cell biology; eicosanoids; endocannabinoids; eosinophils; leukocytes; linoleic acid; neutrophils; polyunsaturated fatty acid
Application summary
Arachidonic acid (AA) is fatty acid mainly found in animals. It plays critical roles in many processes, from fever to reproduction. AA is so important that animals unable to synthesize it, such as the cat, are obligatory carnivorous to obtain the AA from the meat they eat. Humans can however make it from vegetable oils containing linoleic acid. In our body, most of the AA is stored within our cell membranes. Multiple enzymes are responsible for storing AA within our cell membranes and for providing free AA on demand. AA is the precursor of numerous eicosanoids such as prostaglandins and leukotrienes, which participate to a myriad of physiological processes. AA is also the precursor of the main endocannabinoids, which mimic some of the physiological effects of cannabis, as well as displaying many other regulatory functions throughout our organism. Thus, it is not surprizing that AA levels are tightly controlled. Furthermore, many enzymes are involved in the degradation of AA-containing endocannabinoids, although the involved proteome is not completely defined. My NSERC research program focuses at understanding how arachidonic acid (AA) metabolism occurs in inflammatory cells and to define the regulatory mechanisms involved in AA turnover and release. This is important given the important role AA has at regulating the abovementioned functions, notably during the course of inflammation. We recently showed that the fate of AA is diverse in human neutrophils: 1) it is partly transformed into eicosanoids; 2) it is rapidly incorporated into phospholipids. Of note, 3) some of the reacylated AA is rereleased as 2-arachidonoylglycerol (2-AG), an endocannabinoid; While the first two events had previously been documented us and others, we are the first to document the release of 2-AG. The AA-induced 2-AG biosynthesis is prevented by Acyl-CoA synthetase and Acyl-CoA tranferase inhibition, indicating the remodeling of AA into phospholipids. To be adequately observed, we must eliminate the ability of leukocyte to hydrolyze 2-AG. For the next five years, we propose to define, at the cellular and molecular level, wether additional substrates participate to the biosynthetic pathway we unmaked. We will thus investigate numerous unsaturated fatty acids and oxylipins. Finally, and as underscored above, 2-AG is very labile and is hydrolyzed very rapidly (seconds to minutes). While defining which 2-AG lipases were expressed by neutrophils, we pinpointed a new 52 kDa protein not documented for hydrolyzing 2-AG. We will thus identify that protein by mass spectrometry. Once identified, we will confirm using recombinant proteins the selectivity and specificity of the enzyme. In conclusion, this project will provide important insights on the regulation of AA and AA-derived effectors. It will also provide useful data for the understanding of lipid mediator biosynthesis and their role in physiology and will confirm AA as a central regulator of 2-AG synthesis.